BiotechTube

Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) Hexa

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rotavirus Disease

Conditions

Rotavirus Disease

Trial Timeline

Feb 1, 2006 → Nov 1, 2006

NCT ID
NCT00258154

About Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) Hexa

Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) Hexa is a phase 3 stage product being developed by Merck for Rotavirus Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00258154. Target conditions include Rotavirus Disease.

What happened to similar drugs?

1 of 12 similar drugs in Rotavirus Disease were approved

Approved (1) Terminated (1) Active (10)
❌Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
🔄RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
🔄Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
🔄RotaTeq (V260) + IPVMerckPhase 3
🔄Rotateq™ + Comparator: PlaceboMerckPhase 3
✅RotaTeq™ (V260) + DTP-IPVMerckApproved
🔄Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00258154Phase 3Completed

Competing Products

14 competing products in Rotavirus Disease

See all competitors
ProductCompanyStageHype Score
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
32
RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
40
RotaTeq (V260) + IPVMerckPhase 3
40
Rotateq™ + Comparator: PlaceboMerckPhase 3
40
RotaTeq™ (V260) + DTP-IPVMerckApproved
43
Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + PlaceboMerckPhase 1
21
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3
40
V260 + Placebo to V260 + OPV + DTaPMerckPhase 3
40
rotavirus vaccine, live, oral, pentavalent + PlaceboMerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 1
29
RotaTeq™ experimental formulation + RotaTeq™ existing formulationMerckPhase 3
40
Rotarix + RotaTeqMerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™) + Comparator: Comparator: Placebo (unspecified)MerckPhase 3
40